<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30316563</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-0887</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>10</Day>                    </PubDate>                </JournalIssue>                <Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title>                <ISOAbbreviation>Radiother Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Volume effects of radiotherapy on the risk of second primary cancers: A systematic review of clinical and epidemiological studies.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">S0167-8140(18)33500-X</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radonc.2018.09.017</ELocationID>            <Abstract>                <AbstractText>As modern radiotherapy, including intensity-modulated techniques, is associated with high dose gradients to normal tissues and large low-to-moderate dose volumes, the assessment of second primary cancer (SPC) risks requires quantification of dose-volume effects. We conducted a systematic review of clinical and epidemiological studies investigating the effect of the irradiated volume or dose-volume distribution to the remaining volume at risk (RVR) on SPC incidence. We identified eighteen studies comparing SPC risks according to the irradiated volume (i.e., in most studies, the size or number of fields used), and four studies reporting risk estimates according to the dose distribution to the RVR (after whole-body dose reconstruction). An increased risk of SPCs (mainly breast and lung cancers) with extended radiotherapy was observed among patients treated for Hodgkin lymphoma or childhood cancers. However, normal tissue dose distribution was not estimated, limiting the interpretation of those results in terms of volume effects on organs at risk. Studies considering whole-body exposures quantified dose-response relationships for point dose estimates, without accounting for dose-volume distributions. Therefore, they disregarded possible tissue effects (e.g. bystander and abscopal effects, stem cell repopulation) which may play a role in the induction of SPCs. Currently, there is no clinical or epidemiological information about a possible role of high dose gradients in surrounding organs, or increasing volumes of distant tissues exposed to low doses, in the risk of SPCs. Opportunities for future research nevertheless now exist, since methods and tools for estimating individual whole-body dose-volume distributions in large patient populations have been developed.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Journy</LastName>                    <ForeName>Neige</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: neige.journy@gustaveroussy.fr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mansouri</LastName>                    <ForeName>Imène</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Allodji</LastName>                    <ForeName>Rodrigue S</ForeName>                    <Initials>RS</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Demoor-Goldschmidt</LastName>                    <ForeName>Charlotte</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France; Department of Pediatric Onco-hematology, CHU Angers, Angers, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ghazi</LastName>                    <ForeName>Debiche</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Haddy</LastName>                    <ForeName>Nadia</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rubino</LastName>                    <ForeName>Carole</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Veres</LastName>                    <ForeName>Cristina</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zrafi</LastName>                    <ForeName>Wael Salem</ForeName>                    <Initials>WS</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rivera</LastName>                    <ForeName>Sofia</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France; INSERM 1030 Molecular Radiotherapy, Villejuif, France; Paris-Saclay University, Paris-Sud Medical School, Le Kremlin-Bicêtre, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Diallo</LastName>                    <ForeName>Ibrahima</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>De Vathaire</LastName>                    <ForeName>Florent</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U1018, Paris-Sud XI University, Paris-Saclay University, Centre for Research in Epidemiology and Population Health (CESP), &quot;Cancer &amp; Radiations&quot; Group, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>10</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Ireland</Country>            <MedlineTA>Radiother Oncol</MedlineTA>            <NlmUniqueID>8407192</NlmUniqueID>            <ISSNLinking>0167-8140</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Dose–response relationship, radiation</Keyword>            <Keyword MajorTopicYN="N">Neoplasms, radiation-induced</Keyword>            <Keyword MajorTopicYN="N">Radiation dosage</Keyword>            <Keyword MajorTopicYN="N">Radiotherapy</Keyword>            <Keyword MajorTopicYN="N">Review</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30316563</ArticleId>            <ArticleId IdType="pii">S0167-8140(18)33500-X</ArticleId>            <ArticleId IdType="doi">10.1016/j.radonc.2018.09.017</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>